2.23% | % of shares held by all insiders |
118.53% | % of shares held by institutions |
121.24% | % of float held by institutions |
248 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,495,392 | 30 Mar 2024 | 13.78% | 164,333,412 |
BVF Inc. | 4,370,024 | 30 Mar 2024 | 9.27% | 110,561,603 |
Eventide Asset Management LLC | 3,300,400 | 30 Mar 2024 | 7.00% | 83,500,117 |
State Street Corporation | 2,822,472 | 30 Mar 2024 | 5.99% | 71,408,539 |
Janus Henderson Group PLC | 2,767,210 | 30 Mar 2024 | 5.87% | 70,010,410 |
Blackrock Inc. | 2,452,273 | 30 Mar 2024 | 5.20% | 62,042,505 |
Cadian Capital Management, LP | 2,292,567 | 30 Mar 2024 | 4.86% | 58,001,943 |
Vanguard Group Inc | 2,211,685 | 30 Mar 2024 | 4.69% | 55,955,628 |
Rock Springs Capital Management, LP | 1,856,564 | 30 Mar 2024 | 3.94% | 46,971,067 |
Price (T.Rowe) Associates Inc | 1,597,506 | 30 Mar 2024 | 3.39% | 40,416,900 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2,230,272 | 30 Mar 2024 | 4.73% | 56,425,879 |
Vanguard Total Stock Market Index Fund | 1,516,150 | 30 Dec 2023 | 3.22% | 38,358,593 |
Mutual Fund Ser Tr-Eventide Gilead Fund | 1,183,563 | 30 Dec 2023 | 2.51% | 29,944,142 |
Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 1,098,318 | 30 Dec 2023 | 2.33% | 27,787,444 |
Vanguard Extended Market Index Fund | 601,381 | 30 Dec 2023 | 1.28% | 15,214,938 |
iShares Russell 2000 ETF | 600,989 | 30 Mar 2024 | 1.28% | 15,205,021 |
Price (T.Rowe) New Horizons Fund | 504,715 | 30 Dec 2023 | 1.07% | 12,769,289 |
Janus Henderson Global Life Sciences Fund | 485,546 | 30 Dec 2023 | 1.03% | 12,284,313 |
Franklin Strategic Series-Franklin Biotechnology Discove | 312,590 | 30 Jan 2024 | 0.66% | 7,908,526 |
Janus Henderson Venture Fund | 308,194 | 30 Dec 2023 | 0.65% | 7,797,307 |